Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (541-550 of 542) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 542 results.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of <i>cyp51A</i> Mutations on Estimation of Epidemiological Cutoff ValuesA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Pageof 55

Showing results (541-550 of 542) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 542 results.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of <i>cyp51A</i> Mutations on Estimation of Epidemiological Cutoff ValuesA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Pageof 55